Fluorosulfonyl-substituted xanthines as selective irreversible antagonists for the A1-adenosine receptor

被引:34
作者
Beauglehole, AR
Baker, SP
Scammells, PJ [1 ]
机构
[1] Deakin Univ, Ctr Chiral & Mol Technol, Geelong, Vic 3217, Australia
[2] Univ Florida, Dept Pharmacol & Therapeut, Gainesville, FL 32610 USA
关键词
D O I
10.1021/jm000181f
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
FSCPX (1) has been reported to be a potent, selective, and irreversible antagonist for the A(1)-adenosine receptor (AR). To obtain an irreversible A(1)AR antagonist with potentially better stability and to further elucidate the effects of linker structure on the pharmacological characteristics, several new analogues were targeted in which the labile ester linkage of 1 was replaced by more stable functionalities. In particular, alkyl and:amide linkers between the xanthine pharmacophore and the reactive 4-fluorosulfonylphenyl group were explored. The data showed that the chemical composition of the linker affects the affinity and apparent irreversible binding to the A(1)AR. Overall, compound 23b appeared to have the most advantageous characteristics as a potential irreversible ligand for the A(1)AR. These include relatively high affinity for the A(1)AR. as compared to the A(2A)AR, concentration-dependent and selective apparent irreversible binding to the A(1)AR, and ease;of removal of unbound ligand from biological membranes. These :properties indicate that 23b has the potential to be a useful tool for further study of the structure and function of the A(1)AR.
引用
收藏
页码:4973 / 4980
页数:8
相关论文
共 20 条
[1]  
BAKER BR, 1968, J MED CHEM, V11, P666, DOI 10.1021/jm00310a007
[2]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[3]   ADENOSINE RECEPTORS - TARGETS FOR FUTURE DRUGS [J].
DALY, JW .
JOURNAL OF MEDICINAL CHEMISTRY, 1982, 25 (03) :197-207
[4]   STUDIES IN THE PROTECTION OF PYRROLE AND INDOLE-DERIVATIVES [J].
DHANAK, D ;
REESE, CB .
JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1, 1986, (12) :2181-2186
[5]  
DICKINSON KEJ, 1985, MOL PHARMACOL, V27, P499
[6]   PREPARATION OF 2-SUBSTITUTED PYRROLES AND INDOLES BY REGIOSELECTIVE ALKYLATION AND DEPROTECTION OF 1-(2-TRIMETHYLSILYLETHOXYMETHYL)PYRROLE AND 1-(2-TRIMETHYLSILYLETHOXYMETHYL) INDOLE [J].
EDWARDS, MP ;
DOHERTY, AM ;
LEY, SV ;
ORGAN, HM .
TETRAHEDRON, 1986, 42 (13) :3723-3729
[7]   ADENOSINE RECEPTORS - PHARMACOLOGY, STRUCTURE-ACTIVITY-RELATIONSHIPS, AND THERAPEUTIC POTENTIAL [J].
JACOBSON, KA ;
VANGALEN, PJM ;
WILLIAMS, M .
JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (03) :407-422
[8]   BETA-ADRENOCEPTOR METABOLISM IN WILD-TYPE, GS, AND PROTEIN KINASE-A-VARIANT S49 CELLS [J].
JASPER, JR ;
MOTULSKY, HJ ;
MAHAN, LC ;
INSEL, PA .
AMERICAN JOURNAL OF PHYSIOLOGY, 1990, 259 (01) :C41-C46
[9]   PROTECTION OF IMIDAZOLES AS THEIR BETA-TRIMETHYLSILYLETHOXYMETHYL (SEM) DERIVATIVES [J].
LIPSHUTZ, BH ;
VACCARO, W ;
HUFF, B .
TETRAHEDRON LETTERS, 1986, 27 (35) :4095-4098
[10]   Increase in the number, G protein coupling, and efficiency of facilitatory adenosine A2A receptors in the limbic cortex, but not striatum, of aged rats [J].
Lopes, LV ;
Cunha, RA ;
Ribeiro, JA .
JOURNAL OF NEUROCHEMISTRY, 1999, 73 (04) :1733-1738